Cargando…
Rapamycin nanoparticles improves drug bioavailability in PLAM treatment by interstitial injection
BACKGROUND: Pulmonary lymphangiomyomatosis (PLAM) is a rare interstitial lung disease characterized by diffuse cystic changes caused by the destructive proliferation of smooth muscle-like cells or LAM cells. PLAM is more common in young women than other people, and a consensus is lacking regarding P...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463820/ https://www.ncbi.nlm.nih.gov/pubmed/36085075 http://dx.doi.org/10.1186/s13023-022-02511-6 |